Reviewed,
UniProtKB/Swiss-Prot P02763 (A1AG1_HUMAN)
Last modified
February 9, 2010.
Version 122.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Alpha-1-acid glycoprotein 1 Short name=AGP 1 Alternative name(s): Orosomucoid-1 Short name=OMD 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 201 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Appears to function in modulating the activity of the immune system during the acute-phase reaction. |
| Subcellular location | |
| Tissue specificity | Expressed by the liver and secreted in plasma. |
| Induction | Synthesis is controlled by glucocorticoids, interleukin-1 and interleukin-6, It increases 5- to 50-fold upon inflammation. |
| Polymorphism | Three common alleles of ORM1 are known. ORM1*F1 has Gln-38/Val-174; ORM1*F2 has Gln-38/Met-174 and ORM1*S has Arg-38/Val-174. The sequence shown is that of allele ORM1*F1. |
| Sequence similarities | Belongs to the calycin superfamily. Lipocalin family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Acute phase |
| Cellular component | Secreted |
| Coding sequence diversity | Polymorphism |
| Domain | Signal |
| PTM | Disulfide bond Glycoprotein Pyrrolidone carboxylic acid |
| Technical term | 3D-structure Complete proteome Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | acute-phase response Ref.1 Traceable author statement. Source: ProtInc regulation of immune system processInferred from electronic annotation. Source: InterPro |
| Cellular component | extracellular space Traceable author statement. Source: ProtInc |
| Molecular function | protein binding Inferred from physical interaction. Source: IntAct |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 18 | 18 | Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Chain | 19 – 201 | 183 | Alpha-1-acid glycoprotein 1 | PRO_0000017860 | |||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 19 | 1 | Pyrrolidone carboxylic acid Ref.7 | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 33 | 1 | N-linked (GlcNAc...) Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 Ref.9 | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 56 | 1 | N-linked (GlcNAc...) Ref.10 Ref.14 Ref.15 Ref.9 | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 72 | 1 | N-linked (GlcNAc...) Ref.10 Ref.12 Ref.14 Ref.15 Ref.9 | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 93 | 1 | N-linked (GlcNAc...) Ref.10 Ref.12 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 Ref.9 | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 103 | 1 | N-linked (GlcNAc...) Ref.10 Ref.14 Ref.15 Ref.17 | CAR_000170 | |||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 23 ↔ 165 | Ref.9 | |||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 90 ↔ 183 | Ref.9 | |||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 38 | 1 | Q → R in allele ORM1*S. Ref.6 Ref.19 | VAR_013840 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 167 | 1 | R → C: dbSNP rs3182034. | VAR_056166 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 174 | 1 | V → M in allele ORM1*F2. dbSNP rs1126801. Ref.19 | VAR_013841 | |||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 182 | 1 | Missing AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 193 | 1 | Missing AA sequence Ref.8 | ||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||
| Helix | 24 – 26 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 33 – 39 | 7 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 43 – 48 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 53 – 59 | 7 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 62 – 72 | 11 | |||||||||||||||||||||||||||||||||||||||||
| Turn | 73 – 76 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 77 – 86 | 10 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 89 – 99 | 11 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 106 – 109 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 114 – 121 | 8 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 127 – 131 | 5 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 137 – 139 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 143 – 149 | 7 | |||||||||||||||||||||||||||||||||||||||||
| Turn | 153 – 155 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 159 – 166 | 8 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 170 – 172 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 178 – 180 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 184 – 189 | 6 | |||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Structure and expression of the genes coding for human alpha 1-acid glycoprotein." Dente L., Pizza M.G., Metspalu A., Cortese R. EMBO J. 6:2289-2296(1987) [PubMed: 2822385] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Molecular cloning and nucleotide sequence of human alpha 1 acid glycoprotein cDNA." Board P.G., Jones I.M., Bentley A.K. Gene 44:127-131(1986) [PubMed: 3770479] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Structure of the human alpha 1-acid glycoprotein gene: sequence homology with other human acute phase protein genes." Dente L., Ciliberto G., Cortese R. Nucleic Acids Res. 13:3941-3952(1985) [PubMed: 2409529] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [4] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Liver. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ARG-38. Tissue: Liver. |
| [7] | "Structure of alpha 1-acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins." Schmid K., Kaufmann H., Isemura S., Bauer F., Emura J., Motoyama T., Ishiguro M., Nanno S. Biochemistry 12:2711-2724(1973) [PubMed: 4711474] [Abstract] Cited for: PROTEIN SEQUENCE OF 19-129. |
| [8] | "Isolation and partial characterization of the cyanogen bromide fragments of alpha 1-acid glycoprotein and the elucidation of the amino acid sequence of the carboxyl-terminal cyanogen bromide fragment." Ikenaka T., Ishiguro M., Emura J., Kaufmann H., Isemura S., Bauer W., Schmid K. Biochemistry 11:3817-3829(1972) [PubMed: 4561179] [Abstract] Cited for: PROTEIN SEQUENCE OF 129-201. |
| [9] | "The disulfide bonds of alpha1-acid glycoprotein." Schmid K., Buergi W., Collins J.H., Nanno S. Biochemistry 13:2694-2697(1974) [PubMed: 4603214] [Abstract] Cited for: DISULFIDE BONDS. |
| [10] | "Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein." Treuheit M.J., Costello C.E., Halsall H.B. Biochem. J. 283:105-112(1992) [PubMed: 1567356] [Abstract] Cited for: GLYCOSYLATION AT ASN-33; ASN-56; ASN-72; ASN-93 AND ASN-103. |
| [11] | "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry." Zhang H., Li X.-J., Martin D.B., Aebersold R. Nat. Biotechnol. 21:660-666(2003) [PubMed: 12754519] [Abstract] Cited for: GLYCOSYLATION AT ASN-33. |
| [12] | "A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation." Hagglund P., Bunkenborg J., Elortza F., Jensen O.N., Roepstorff P. J. Proteome Res. 3:556-566(2004) [PubMed: 15253437] [Abstract] Cited for: GLYCOSYLATION AT ASN-33; ASN-72 AND ASN-93, MASS SPECTROMETRY. |
| [13] | "A proteomic analysis of human bile." Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H., Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A. Mol. Cell. Proteomics 3:715-728(2004) [PubMed: 15084671] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33 AND ASN-93, MASS SPECTROMETRY. Tissue: Bile. |
| [14] | "Screening for N-glycosylated proteins by liquid chromatography mass spectrometry." Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R. Proteomics 4:454-465(2004) [PubMed: 14760718] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93 AND ASN-103, MASS SPECTROMETRY. Tissue: Plasma. |
| [15] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed: 16335952] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93 AND ASN-103, MASS SPECTROMETRY. Tissue: Plasma. |
| [16] | "Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry." Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T., Loo J.A. J. Proteome Res. 5:1493-1503(2006) [PubMed: 16740002] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93, MASS SPECTROMETRY. Tissue: Saliva. |
| [17] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed: 19159218] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93 AND ASN-103, MASS SPECTROMETRY. Tissue: Liver. |
| [18] | "Three-dimensional modeling of the protein moiety of human alpha1-acid glycoprotein, a lipocalin-family member." Rojo-Dominguez A., Hernandez-Arana A. Protein Seq. Data Anal. 5:349-355(1993) Cited for: 3D-STRUCTURE MODELING. |
| [19] | "Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S." Yuasa I., Umetsu K., Vogt U., Nakamura H., Nanba E., Tamaki N., Irizawa Y. Hum. Genet. 99:393-398(1997) [PubMed: 9050929] [Abstract] Cited for: VARIANTS ARG-38 AND MET-174. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X02544 mRNA. Translation: CAA26397.1. M13692 mRNA. Translation: AAA35515.1. X05779 X05784 Genomic DNA. Translation: CAA29229.1. Sequence problems.X06676 Genomic DNA. No translation available. X06680 Genomic DNA. No translation available. BT019790 mRNA. Translation: AAV38593.1. AK312035 mRNA. Translation: BAG34972.1. BC026238 mRNA. Translation: AAH26238.1. | ||||||||||||
| IPI | IPI00022429. | ||||||||||||
| PIR | OMHU1. A28346. | ||||||||||||
| RefSeq | NP_000598.2. | ||||||||||||
| UniGene | Hs.522356 | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | P02763. 2 interactions. | ||||||||||||
| STRING | P02763. | ||||||||||||
PTM databases | |||||||||||||
| GlycoSuiteDB | P02763. | ||||||||||||
2-D gel databases | |||||||||||||
| SWISS-2DPAGE | P02763. | ||||||||||||
| Siena-2DPAGE | P02763. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | P02763. | ||||||||||||
| PRIDE | P02763. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000259396; ENSP00000259396; ENSG00000229314; Homo sapiens. [Genome view] | ||||||||||||
| GeneID | 5004. | ||||||||||||
| KEGG | hsa:5004. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 5004. | ||||||||||||
| GeneCards | GC09P116125. | ||||||||||||
| HGNC | HGNC:8498. ORM1. | ||||||||||||
| HPA | CAB006265. | ||||||||||||
| MIM | 138600. gene. | ||||||||||||
| PharmGKB | PA260. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | prNOG11781. | ||||||||||||
| HOGENOM | HBG126438. | ||||||||||||
| HOVERGEN | P02763. | ||||||||||||
| InParanoid | P02763. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P02763. | ||||||||||||
| Bgee | P02763. | ||||||||||||
| CleanEx | HS_ORM1. | ||||||||||||
| Genevestigator | P02763. | ||||||||||||
| GermOnline | ENSG00000187681. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR001500. A1A_glycop. IPR012674. Calycin. IPR011038. Calycin-like. IPR000566. Lipocln_cytosolic_FA_bd. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:2.40.128.20. Calycin. 1 hit. | ||||||||||||
| PANTHER | PTHR11967. A1A_glycop. 1 hit. | ||||||||||||
| Pfam | PF00061. Lipocalin. 1 hit. [Graphical view] | ||||||||||||
| PIRSF | PIRSF036899. AGP. 1 hit. | ||||||||||||
| PRINTS | PR00708. A1AGLPROTEIN. | ||||||||||||
| PROSITE | PS00213. LIPOCALIN. False negative. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| DrugBank | DB01418. Acenocoumarol. DB00802. Alfentanil. DB01429. Aprindine. DB00280. Disopyramide. DB01359. Penbutolol. DB00946. Phenprocoumon. DB00908. Quinidine. DB00706. Tamsulosin. | ||||||||||||
| NextBio | 19272. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | A1AG1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P02763 Secondary accession number(s): Q5U067, Q8TC16 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


